The relationship between genetic variation in the alpha 2A adrenergic receptor and cardiovascular effect of dexmedetomidine in Han population

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-16008350

Enrollment

Unknown

Registered

2016-04-24

Start date

2016-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

one group:dexmedetomidine intravenous bolus

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Han nationality, no hypertension, diabetes and other important organ history, aged 18-65 years old.

Exclusion criteria

Exclusion criteria: main organ disease, obesity (> 30% of ideal body weight), long-term medication history, dexmedetomidine contraindications.

Design outcomes

Primary

Measure	Time frame
Blood pressure;Heart rate;	—

Countries

China

Contacts

Public ContactKui-Rong Wang

The First Affiliated Hospital, College of Medicine, Zhejiang University

wangkuirong@hotmail.com+86 13957100541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026